4th Quarter - Report
ADAPTIVE BIOTECHNOLOGIES for ADAPTIVE BIOTECHNOLOGIES
Client
Income
—
Expenses
$190,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 6102 and S.3404; The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020; all provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAMELA LYNN BRADLEY | covered legislative branch official |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.